As obesity drug developers compete for the highest weight-loss efficacy, experts contend that overall health ...

Glucagon-like peptide-1 agonists, a class of medications known as GLP-1s, have grown in popularity, initially for the treatment of type 2 diabetes ...

Popular prescription weight-loss drugs called GLP-1 receptor agonists are now frequently used by type 1 diabetes patients, despite limited data on the drugs’ safety and effectiveness in this patient ...

Plenty of folks have been using GLP-1s — generic versions of popular weight loss drugs such as Ozempic and Zepbound — to jump ...

Ask a Doctor is new series of physician-authored columns offering insights and advice on common health topics. It is not a ...

Genetics or hormonal changes can pose challenges for losing weight, as you may know firsthand. Like many others struggling to ...

Tirzepatide has been shown to help people lose more weight compared to semaglutide at the dosage regimens currently available ...

GLP-1 drugs such as semaglutide ... Their popularity as a tool for weight loss skyrocketed after the US Food and Drug Administration (FDA) approved semaglutide for weight management in 2021.

Customers who struggle to afford the $1,000-plus list price for weight-loss drugs Zepbound and Wegovy can buy now and pay ...

Cigna (CI) CEO David Cordani is not convinced of the benefits of GLP-1s for weight-loss patients and said the ... including GLP-1 benefits and coverage. Cigna CEO David Cordani speaks at The ...

surged ~31% in after-hours trading Thursday after posting preliminary data on weight loss associated with its gastric balloon in combination with Novo Nordisk's (NVO) GLP-1 semaglutide.